JAMES E. LOVELESS
Impact in
- Rheumatology top 0.5%
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
- Immunology top 10%
- T-cell and B-cell Immunology
- Biosimilars and Bioanalytical Methods
Papers in
-
- Rheumatoid Arthritis Research and Therapies 5
-
- Sarcoidosis and Beryllium Toxicity Research 1
- Co-authors
- Paul E. Emery (4 shared papers)Edward Clark Keystone (3 shared papers)Gerd Rüdiger Burmester (3 shared papers)Maxime Dougados (2 shared papers)Stanley B. Cohen (2 shared papers)Matthew W. Cravets (3 shared papers)Mark C. Totoritis (1 shared paper)Mark C. Genovese (1 shared paper)
- Journals
- Annals of the Rheumatic Diseases (2 papers)The Journal of Immunology (1 paper)The Journal of Rheumatology (1 paper)Arthritis Care & Research (1 paper)Arthritis & Rheumatism (1 paper)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
JAMES E. LOVELESS
7 papers receiving 1.5k citations
JAMES E. LOVELESS's Hit Papers
Peers
Comparison fields: 5 of 64
- Rheumatology 1.1k
- Immunology 170
- Pathology and Forensic Medicine 97
- Hematology 45
- Physiology 65
Countries citing papers authored by JAMES E. LOVELESS
This map shows the geographic impact of JAMES E. LOVELESS's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by JAMES E. LOVELESS with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites JAMES E. LOVELESS more than expected).
Fields of papers citing papers by JAMES E. LOVELESS
This network shows the impact of papers produced by JAMES E. LOVELESS. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by JAMES E. LOVELESS. The network helps show where JAMES E. LOVELESS may publish in the future.
Co-authors
The 25 scholars most cited alongside JAMES E. LOVELESS, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Rituximab for rheumatoid arthritis refractory to anti–tumor necrosis factor therapy: Results of a multicenter, randomized, double‐blind, placebo‐controlled, phase III trial evaluating primary efficacy and safety at twenty‐four weeks Hit paper breakdown → | 2006 | 1382 |
| 2 | 2008 | 88 | |
| 3 | 1994 | 58 | |
| 4 | 2012 | 57 | |
| 5 | Improved quality of life with rituximab plus methotrexate in patients with active rheumatoid arthritis who experienced inadequate response to one or more anti-TNF alpha therapies | 2006 | 8 |
| 6 | Oral glucocorticoids have no impact on the efficacy or safety profile of rituximab in rheumatoid arthritis patients with inadequate response to TNF inhibitors (REFLEX study) | 2006 | 4 |
| 7 | 2026 | 1 |
About JAMES E. LOVELESS
JAMES E. LOVELESS is a scholar working on Rheumatology, Physiology, Epidemiology, Nuclear Energy and Engineering and Waste Management and Disposal, having authored 7 papers that have together received 1.6k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (5 papers), Sarcoidosis and Beryllium Toxicity Research (1 paper) and Herpesvirus Infections and Treatments (1 paper). The work is most often cited by research in Rheumatology (1.1k citations), Immunology (170 citations), Pathology and Forensic Medicine (97 citations), Hematology (45 citations) and Physiology (65 citations). JAMES E. LOVELESS has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Paul E. Emery, Edward Clark Keystone, Gerd Rüdiger Burmester, Maxime Dougados, Stanley B. Cohen, Matthew W. Cravets, Mark C. Totoritis, Mark C. Genovese, Eva W. Hessey and Maria Greenwald. Their work appears in journals such as Annals of the Rheumatic Diseases, The Journal of Immunology, The Journal of Rheumatology, Arthritis Care & Research and Arthritis & Rheumatism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.